 |
A Company on a Mission to Revolutionize Mental Healthcare. Here’s How.
When Stockhouse Editorial last caught up with Cybin Inc. back in October 2021, our audience learned about a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches, and potential treatment regimens for psychiatric disorders. Stockhouse Media’s Dave Jackson was joined, once again, by company CEO Doug Drysdale to get our investor audience up-to-date on all things Cybin Inc.
Read the Full Story Here
Weekly Update - Top Cannabis News Stories
1 | Top Story: New cannabinoid-based product seeks emergency use authorization against COVID.
2 | THC BioMed Ltd. sells Canada’s lowest priced edible in Ontario Cannabis Store.
3 | Nextleaf Solutions Ltd. provides corporate update and comments on year-end financials
4 | Heritage Cannabis Holdings Corp. announces nine new product launches in Ontario cannabis market.
5 | Sproutly Canada Inc. announces financial results for Q3 Fiscal 2021.
Top Cannabis Stocks | Jan 27 to Feb 2, 2022
1. T.HEXO | 35,378 views | HEXO Corp.
2. T.WEED |23,217 views | Canopy Growth Corporation.
3. TLRY | 17,105 views | Tilray Brands Inc.
4. T.AH | 15,839 views | Aleafia Health Inc.
5. T.TBP | 7,315 views | Tetra Bio-Pharma Inc.
6. C.OILS | 6,567 views | Nextleaf Solutions Ltd.
FULL DISCLOSURE: Cybin Inc. is a client of Stockhouse Publishing.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.